Satellos Bioscience Inc. (TSX:MSCL)
Canada · Delayed Price · Currency is CAD 9.75
-0.02 (-0.20%)
Mar 24, 2026, 2:15 PM EST
Satellos Bioscience Market Cap
Satellos Bioscience has a market cap or net worth of CAD 201.53 million as of March 24, 2026. Its market cap has increased by 44.68% in one year.
Market Cap
201.53M
Enterprise Value
153.31M
Revenue
n/a
Ranking
n/a
PE Ratio
n/a
Stock Price
9.75
Market Cap Chart
Since August 19, 2021, Satellos Bioscience's market cap has increased from 58.83M to 201.53M, an increase of 242.55%. That is a compound annual growth rate of 30.73%.
Market Cap History
| Date | Market Cap | % Change |
|---|---|---|
| Mar 23, 2026 | 201.53M | 64.60% |
| Dec 31, 2025 | 122.43M | -11.04% |
| Dec 31, 2024 | 137.63M | 183.77% |
| Dec 29, 2023 | 48.50M | 427.44% |
| Dec 30, 2022 | 9.20M | -72.13% |
| Dec 31, 2021 | 33.00M | -43.91% |
| Aug 19, 2021 | 58.83M | - |
Market Capitalization
Market capitalization, also called net worth, is the total value of all of a company's outstanding shares. It is calculated by multiplying the stock price by the number of shares outstanding.
Formula: Market Cap = Stock Price * Shares Outstanding
Full DefinitionRelated Stocks
| Company | Market Cap |
|---|---|
| Bright Minds Biosciences | 979.01M |
| Eupraxia Pharmaceuticals | 602.12M |
| Helix BioPharma | 126.02M |
| ME Therapeutics Holdings | 75.12M |
| Sharp Therapeutics | 67.67M |
| NurExone Biologic | 58.87M |
| Medicenna Therapeutics | 58.39M |
| Sernova Biotherapeutics | 52.16M |